Metformin as Host-Directed Therapy for TB Treatment: Scoping Review
Tuberculosis (TB) disease is an international health concern caused by the bacteria Mycobacterium tuberculosis (Mtb). Evolution of multi-drug-resistant strains may cause bacterial persistence, rendering existing antibiotics ineffective. Hence, development of new or repurposing of currently approved...
Main Authors: | Nikita Naicker, Alex Sigal, Kogieleum Naidoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.00435/full |
Similar Items
-
Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb
by: Naicker N, et al.
Published: (2023-06-01) -
The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy
by: Deepthi Shankaran, et al.
Published: (2023-01-01) -
Editorial: Host-Directed Therapies for Tuberculosis
by: Diego L. Costa, et al.
Published: (2021-08-01) -
Autophagy Induction as a Host-Directed Therapeutic Strategy against <em>Mycobacterium tuberculosis</em> Infection
by: Harresh Adikesavalu, et al.
Published: (2021-05-01) -
Host-Directed Therapies for Tuberculosis
by: Eui-Kwon Jeong, et al.
Published: (2022-11-01)